Gastroesophageal Reflux Disease. Gastro-oesophageal reflux disease with oesophagitis
Conditions
Interventions
Intervention 1: intervention: holding dietary training class according to the determined temperament along with slide presentation and giving educational brochure, face to face, for 1.5 hours, about
intervention: holding dietary training class according to the determined temperament along with slide presentation and giving educational brochure, face to face, for 1.5 hours, about using and not us
control: education of usual modern medicine diet plan along with slide presentation and giving educational brochure, face to face, for 1.5 hours, about using and not using foods for 2 weeks
Sponsors
Research department of Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Middle-aged people ranged from 35 to 65 years old; Living in Mashhad; Visit in spring (from 15 March 1391 until June 1392); Be at least literate and Persian language; At least twice a week have heartburn or reflux; A gastroenterologist confirmed reflux disease letter Exclusion criteria: Experience in event cause stress in the last month; Pregnancy; members of the healthcare team; participation in similar studies with nutritional education for Gastroesophageal Reflux Disease; receive training about Gastroesophageal Reflux Disease from other sources or similar treatment; patients with GERD complication (esophageal stricture and gastric bleeding); People who have been anti-reflux surgery, gastric resections and Vagotomy; People who have some disease (patients with scleroderma, connective tissue disease, diabetes mellitus, acit, hypo and hyper thyroidis and amyloidosis, patients with drug and alcohol addiction, cancer, impaired swallowing (dysphagia) and weight loss subsequently, patients with gastrointestinal bleeding requiring hospitalization); The drugs inducing reflux (anticholinergic drugs, Dopamine, Morphine, Nitrates, Caffeine, Theophylline and Diazepam); lack of interest in continuing the study or getting out of reach, like traveling or changing treatment regimen
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency of heartburn and reflux. Timepoint: before intervention and 2 weeks after that. Method of measurement: times in 3 days.;Intensity of heartburn and reflux. Timepoint: before intervention and 2 weeks after that. Method of measurement: 10 graded scale.;Duration of heartburn and reflux. Timepoint: before intervention and 2 weeks after that. Method of measurement: minute.;Heartburn transmission. Timepoint: before intervention and 2 weeks after that. Method of measurement: heartburn, to half of sternum, sternum, sternum and neck.;Complication symptoms. Timepoint: before intervention and 2 weeks after that. Method of measurement: times in 3 days. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: before intervention and 2 weeks after that. Method of measurement: the score from GERD-Health Related Quality of Life. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactKhadije Harati
Mashhad University of Medical Sciences
Outcome results
None listed